The ASX slipped as Wall Street’s tech wobble pushed markets into risk-off mode, dragging miners, gold stocks and tech lower.
The US Food and Drug Administration only asked Botanix for a small change – but it led to a 25 per cent drop for the ASX health stock. The FDA has requested changes to the product use instructions – a ...
Most brokers think the ASX share will continue outperforming. The post Can this ASX gold stock keep surging after hitting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback